Find a TenderAwarded without competitionContract details notice

Published 7 Sept 2026, 13:21 BST

Official UK procurement notice

AGALSIDASE ALFA 3.5MG/3.5ML CONCENTRATE FOR SOLUTION FOR INFUSION, 3.5 mL, vial, PACK OF 1 (HOMECARE)

Official notice

Authority: Belfast Health and Social Care Trust (Central government)

Direct award

Sectors: Medical Devices & Pharma (33) Delivery: Northern Ireland (UKN)

Awarded value£670,000published award · exc. VAT

Awarded 8 Sept 2026no call for competition

Awarded to Sciensus Pharma Services Ltd

What is being bought

Published requirement description

PROCUREMENT OF AGALSIDASE ALFA 3.5MG/3.5ML CONCENTRATE FOR SOLUTION FOR INFUSION, 3.5 mL, vial, PACK OF 1 (HOMECARE)

The lotProcurement structure

single lot · no lot value published

Lot #1Awarded

Delivery: Northern Ireland

33600000 Pharmaceutical products

Procedure terms & legal framework

From the official record

Procedure method: Direct award
Legal basis: UKPGA · 2023/54 Procurement Act 2023
Notice status: Awarded without competition
Procurement threshold: Unspecified in notice
Regulatory regime: Standard
Commercial structure: Stand-alone contract (no framework)
Competition type: Direct award (no call for competition)
GPA / WTO covered: Unspecified in notice
Recurring procurement: Unspecified in notice
First published: 7 Sept 2026, 13:21 BST
Last source update: 29 Sept 2026, 11:56 BST
Authority reference: DACPM2026-63
FTS notice number: 2026/S 000-091789
Latest notice: Contract details notice (UK7)
Delivery area: Northern Ireland (UKN)
Official registry OCID: ocds-h6vhtk-06f379 Find a Tender

Why no open competition: Additional Repeat Extension Partial Replacement
Published justification: These essential medicines are required from this supplier to ensure continuity of patient care, specifically for homecare support. The absence of competition is not the artificial narrowing of the parameters of the procurement

How it was run

Official notice

Submission deadline: —

Timeline

18 Sept 2026 → 29 Sept 2026 · 2 dates

Standstill ends34 days ago
18 Sept 2026, 23:59 BST
Notice published23 days ago
29 Sept 2026, 11:56 BST

Notice history

4 events · 3 releases on Find a Tender · since 7 Sept 2026

Transparency notice published
7 Sept 2026, 13:21 BST
UK5
Contract award notice published
8 Sept 2026, 10:22 BST
UK6
Contract signature expected
19 Sept 2026, 23:59 BST
scheduled
Contract details notice published
29 Sept 2026, 11:56 BST
UK7

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast

Awards 1

Awarded value £670,0001 award exc. VAT

Contracts signed 1latest 29 Sept 2026

Awarded to	Value	Date	Status
Sciensus Pharma Services Ltd19 Sept 2026 – 30 Sept 2028	£670,000	8 Sept 2026	Awarded

Contracts

Contract 1 · Sciensus Pharma Services Ltd
Signed
29 Sept 2026
Value
£670,000
Period
29 Sept 2026 – 30 Sept 2028
Status
active
No agreed KPIs: The contract value is below the relevant threshold for Key Performance Indicators.

Contracting authority & participating public bodies

Belfast Health & Social Care Trust

Contracting authorityPublic authority - central governmentNorthern Irish devolved regulations apply GB-PPON: PLQJ-5727-JCLR Trust Headquarters, 2nd Floor, Non Clinical Support Building, Royal Victoria Hospital, Belfast, Northern Ireland, BT12 6BAContact email

Bidders & participating suppliers

1 commercial party on the notice

SCIENSUS PHARMA SERVICES LIMITEDAwarded supplierGB-COH: 02759609GB-PPON: PXLC-2487-LQPH 20 Eastbourne Terrace, London, London, W2 6LGContact email

Official documents & specifications (3)

Official links; attachments are not copied

Notices published for this procedure

Contract details notice contractContract details noticeUK7Contract details notice on Find a Tender29 Sept 2026, 11:56 BST
Contract award notice awardContract award noticeUK6Contract award notice on Find a Tender8 Sept 2026, 10:22 BST
Transparency notice awardTransparency noticeUK5Transparency notice on Find a Tender7 Sept 2026, 13:21 BST